Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Feasibility of remote self-administered cognitive assessment in an Alzheimer's disease treatment clinic 2026-09-16
  2. Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type 2026-09-15
  3. Detection and Continuous Monitoring of Memory Dysfunction in Mild Cognitive Impairment and Healthy Aging Through Adaptive Computational Phenotyping 2026-09-12

Studies

847 studies carry this tag.

Date range

1982 to 2026

Top journals

  • Neurology 63
  • Journal of Alzheimer's disease : JAD 31
  • Archives of neurology 30
  • Alzheimer s & Dementia 25
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 21

315 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Usability of a Tablet-Based Cognitive Assessment Administered by Medical Assistants in General Practice: Implementation Study

    ✓ Peer-reviewed alzhub usefulness score 34 out of 100. JMIR Formative Research 2025-12-22 Getting a diagnosis

    The results indicated good usability for the MoCA Duo.

  2. Montreal Cognitive Assessment (MoCA) Scale: Strengths, Limitations, and Implication for Clinical Practice

    ✓ Peer-reviewed alzhub usefulness score 32 out of 100. Iranian Journal of Psychiatry 2025-12-20 Getting a diagnosis

    The MoCA shows superior sensitivity for MCI detection compared to the Mini-Mental State Examination (MMSE), with strengths in brevity, multidomain coverage, and accessibility.

  3. Investigating the factor structure of the Montreal Cognitive Assessment: a qualitative review

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. Frontiers in Psychology 2025-12-17 Getting a diagnosis

    Across CTT studies, findings ranged from two-factor to hierarchical multi-factor models, with a general cognitive factor frequently emerging.

  4. Prevalence of dementia and mild cognitive impairment in the Mexican population: evidence from Mex-Cog, a harmonized cognitive assessment protocol study

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. The Journals of Gerontology Series B 2025-12-17 Getting a diagnosis

    We estimated the prevalence of dementia at 6.7% [95% confidence interval (CI): 5.4-8.0] and MCI at 10% (95% CI: 8.7-11.7).

  5. Beyond the Clock: Exploring Multimodal Behavior Markers of Mild Cognitive Impairment in Older Adults during Clock Drawing Test

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies 2025-12-02 Mild cognitive impairment

    Early detection of Mild Cognitive Impairment (MCI) offers a critical window for intervention before progression to dementia.

  6. The primary outcome of this study will be the total score on the Montreal Cognitive Assessment (MOCA).

  7. Brain Age Gap Predicts Progression to Dementia in SCD and MCI

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer s & Dementia 2025-12-01 Cognitive tests and assessment

    224 subjects progressed to dementia (SCD=38 (9.72%), MCI=186 (50.8%)).

  8. Comparison of the Montreal Cognitive Assessment and the Mini‐Mental State Examination in community‐dwelling very old Blacks/African Americans

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Alzheimer s & Dementia 2025-12-01 Getting a diagnosis

    Participants had age mean = 81.7, SD = 4.5, range=75-93; educational attainment mean = 14.6, SD = 4.0, range=7-22, 17.2% < 12; 86.2% were women.

  9. Does Demographic Normalisation Improve the Accuracy of the MoCA and the MMSE for Detecting Mild Cognitive Impairment and Early Dementia ?

    ✓ Peer-reviewed alzhub usefulness score 33 out of 100. Alzheimer s & Dementia 2025-12-01 Cognitive tests and assessment

    Surprisingly, demographic normalisation worsened rather than improved diagnostic accuracy for detecting MCI with both MoCA and MMSE, reducing their effectiveness as diagnostic tools and confirming our hypothesis.

  10. The Relationship Between Brain Structure and Neuropsychiatric Symptoms in Patients With Mild Cognitive Impairment and Alzheimer's Dementia

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. International Journal of Geriatric Psychiatry 2025-12-01 Mild cognitive impairment

    All volumes showed the smallest in dementia, the intermediate in MCI, and the largest in healthy controls.

  11. Time‐dependent biomarker accuracy in forecasting mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer s & Dementia 2025-12-01 Mild cognitive impairment

    Neurophysiological activity features and tau pet provided additional information to the clinical model when acquired up to ∼4 years prior to diagnosis, but their accuracy decreased at larger intervals.

  12. Clinical and neuropsychological features associated with progression in subjective cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in Aging Neuroscience 2025-11-26 Mild cognitive impairment

    At baseline, SCDp were older, had a higher prevalence of hypertension and hypercholesterolemia and had worst performance on tests related to processing speed, verbal fluency, visual memory, verbal memory, and executive functioning.

  13. Clinical and Biological Significance of Neuroinflammation Indicators to Predict the Course of Amnestic Mild Cognitive Impairment

    ✓ Peer-reviewed alzhub usefulness score 30 out of 100. Psikhiatriya 2025-11-25 Mild cognitive impairment

    the cytokines set and immune response indicators have been identified.

  14. Effectiveness of a 52-week multidomain intervention to maintain cognitive function in patients with mild cognitive impairment: a randomized controlled trial

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Scientific Reports 2025-11-20 Prevention trials

    Mild cognitive impairment (MCI) increases the risk of dementia.

  15. Using machine learning for detection of Parkinson’s disease and mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. PLoS ONE 2025-11-19 Mild cognitive impairment

    Overall, both machine learning techniques had an equivalent performance.

  16. An Ultra-Brief Informant Questionnaire for Case Finding of Cognitive Impairment Across Diverse Literacy: Diagnostic Accuracy Study

    ✓ Peer-reviewed alzhub usefulness score 32 out of 100. JMIR Aging 2025-11-14 Getting a diagnosis

    This ultra-brief questionnaire enables rapid screening for cognitive impairment (in <1 min) by family members or as part of community geriatric assessments.

  17. Predicting mild cognitive impairment in patients with Parkinson’s disease by integrating striatal MRI radiomics with clinical features

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. BMC Medical Imaging 2025-11-14 Mild cognitive impairment

    Age and years of education (YOE) were identified as independent clinical risk factors for PD-MCI.

  18. Predictors of Transition from Mild Cognitive Impairment to Normal Cognition and Dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Behavioral Sciences 2025-11-14 Disparities

    Mild cognitive impairment (MCI) represents a heterogeneous state between normal aging and dementia, with varied transition pathways.

  19. Mild cognitive impairment and neuropsychological examination

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Frontiers in Psychology 2025-11-06 Mild cognitive impairment

    The paper discusses according to prevailing diagnostic systems and algorithms, which cognitive domains that are relevant to investigate, which tests that may be relevant, what kind of norms have satisfactory quality, which cut-off scores do best balance sensitivity and specificity in a neurodiagnostic context, and what kind of conclusions and recommendations that can be drawn from neuropsychological findings.

  20. Missing data and imputation in the international studies following the Harmonized Cognitive Assessment Protocol

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. The Journals of Gerontology Series B 2025-11-04 Getting a diagnosis

    Various missing codes were used to document reasons for missingness.

  21. Neurobiological correlates of Mild Behavioral Impairment: a systematic review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. Alzheimer's research & therapy 2025-10-21 Inflammation and the immune system

    Across studies, MBI appears to be linked to specific neurobiological markers of AD, including Aβ and tau brain deposition, as well as alterations in the mesolimbic pathway and neurodegenerative and neuroinflammatory fluid biomarker levels.

  22. Eye-tracking-based tablet application for enhanced cognitive assessment: a clinical trial for software as a medical device (SaMD)

    ✓ Peer-reviewed alzhub usefulness score 35 out of 100. GeroScience 2025-10-20 Getting a diagnosis

    Efficient screening tools for cognitive decline and dementia are in high demand.

  23. APPLE-Tree is an accessible intervention associated with small improvements in cognition, although these results were not statistically significant.

  24. The validated nomogram enables individualized MCI risk stratification, supporting targeted community prevention strategies.

  25. Chronic rhinosinusitis and cognition: a systematic review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Rhinology 2025-10-01 Inflammation and the immune system

    CRS is associated with 9% poorer global cognitive function, while CRS treatment is associated with 8-9% improvements in processing speed and working memory.

  26. Electroencephalography‐based signatures of cognitive resilience in individuals with stable mild cognitive impairment despite carrying a high‐risk for progression to dementia

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Alzheimer s & Dementia Translational Research & Clinical Interventions 2025-10-01 Mild cognitive impairment

    Compared with sMCI-resilient subjects, cMCI individuals exhibited increased frontal delta power, reduced posterior alpha power, and an elevated delta/alpha ratio in the right temporal region, consistent with cortical dysfunction.

  27. Evaluating cognitive impairment among a geriatric population in India using the Indian Council of Medical Research (ICMR)–multilingual dementia research and assessment (MUDRA) toolbox

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Indian Journal of Psychiatry 2025-10-01 Cognitive tests and assessment

    Among 1013 participants, 847 screened positive on MoCA (70.4% mild, 13.2% moderate) for cognitive impairment and were assessed further for other domains of ICMR-MUDRA toolbox.

  28. Diabetic retinopathy as the primary predictor of mild cognitive impairment in type 2 diabetes: Insights from machine learning models

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. PLoS ONE 2025-09-26 Mild cognitive impairment

    Mild cognitive impairment (MCI) is a significant and increasingly recognized problem in individuals with type 2 diabetes mellitus (T2DM).

  29. Handwriting in Mild Cognitive Impairment: Reliability Assessment and Machine Learning–Based Screening

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. JMIR Aging 2025-09-23 Digital health tools

    The presented results suggest the suitability of ecological handwriting analysis for the all-around monitoring of MCI, from early screening to disease progression evaluation.

  30. This study utilized an initial dataset of 188,700 participant records from NACC.

  31. Economic evaluation of a digital health intervention for preventing dementia in Canadians with mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Frontiers in Public Health 2025-09-19 Digital health tools

    Dementia poses an on-going Canadian challenge due to an aging population, with cases projected to rise significantly by 2050.

  32. Machine learning approaches to racial/ethnic differences in social determinants of mild cognitive impairment and its progression to dementia in the All of Us Research Program

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. The Journals of Gerontology Series B 2025-09-19 Digital health tools

    MCI prevalence was comparable across groups (7.5%-8.0%), but progression to dementia varied (9.4% Black vs. 11.4% Other).

  33. The analysis of the gut microbiome during liver disease progression led to the identification of biomarkers for related mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Frontiers in Microbiology 2025-09-16 Mild cognitive impairment

    could serve as potential biomarkers for NAFLD-associated mild cognitive impairment; 3) bacterial metabolic functions involved in sugar degradation and the breakdown of tryptophan and glutamate were downregulated and linked to CXCL13 plasma levels and neuroinflammation; 4) correlations between SCFA concentrations disappeared with liver disease and cognitive impairment.

  34. Mapping the research landscape of Mild Cognitive Impairment in Parkinson's disease: a bibliometric and visualization analysis

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in aging neuroscience 2025-09-10 Inflammation and the immune system

    Mild cognitive impairment in Parkinson's disease research has progressed from basic mechanism exploration to a multidisciplinary, integrated clinical-basic stage, following an evolutionary path of "pathological mechanism - clinical phenotype - biomarker - intervention strategy."

  35. Early detection of cognitive decline in older adults is essential for implementing timely interventions.

  36. Cardiometabolic disorders and mild cognitive impairment in White and Black Americans

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Alzheimer s & Dementia 2025-09-01 Mild cognitive impairment

    Controlling for demographic/health variables, individuals with aMCI, though not naMCI, showed a higher likelihood of hypertension, diabetes, and hyperlipidemia compared to cognitively normal counterparts, though no differences between aMCI/naMCI.

  37. Early Alzheimer’s disease (mild cognitive impairment or mild dementia): Prevalence, diagnostics, treatment options, and guidelines in Asia, Australasia, and Pacific nations countries

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. The Journal of Prevention of Alzheimer s Disease 2025-08-30 How common it is

    Early diagnosis of mild cognitive impairment (MCI) and Alzheimer's disease (AD) with mild dementia is becoming increasingly important to enable patients to receive appropriate treatment with available amyloid-targeting therapies.

  38. Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson’s disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Frontiers in Neurology 2025-08-29 Mild cognitive impairment

    Parkinson's disease (PD), as a common neurodegenerative disorder, its associated mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) is a key prodromal stage in the progression to PD-dementia (PDD).

  39. Neurodetector: EEG-Based Cognitive Assessment Using Event-Related Potentials as a Virtual Switch

    ✓ Peer-reviewed alzhub usefulness score 35 out of 100. Brain Sciences 2025-08-27 Getting a diagnosis

    The participants controlled the EEG Switch above chance level across all tasks.

  40. Supporting Individuals With Cognitive Impairment and Family Members in Rural Communities: Protocol for a Mixed Methods Digital Health Study

    ✓ Peer-reviewed alzhub usefulness score 33 out of 100. JMIR Research Protocols 2025-08-27 Digital health tools

    Data from the qualitative interviews will provide dyad preferences for intervention development.

  41. Disagreement between self- and informant-reported memory complaints and progression of mild cognitive impairment to dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Aging & Mental Health 2025-08-26 Mild cognitive impairment

    Underreporters showed lower cognitive performance (p = 0.021), which did not translate into higher self-report SMC (p = 0.092).

  42. Mild Cognitive Impairment: A Pre-Dementia Syndrome

    ✓ Peer-reviewed alzhub usefulness score 29 out of 100. Batna Journal of Medical Sciences (BJMS) 2025-08-25 Mild cognitive impairment

    Mild Cognitive Impairment (MCI) is a neuropsychological clinical condition regarded as a prodromal stage of dementia, characterized by cognitive decline without significant impairment in daily functioning or autonomy.

  43. A nomogram for predicting post-stroke cognitive impairment no dementia in patients with first-ever mild ischemic stroke

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Frontiers in Neurology 2025-08-19 Vascular contributions

    This validated nomogram incorporating clinical, biochemical, and neuroimaging biomarkers provides a robust tool for individualized PSCIND risk assessment in first-ever MIS patients, with potential to guide targeted interventions and cognitive monitoring.

  44. A Scoping Review of Clinical Utility from the Montreal Cognitive Assessment Memory Index Score

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. Journal of Geriatric Psychiatry and Neurology 2025-08-18 Getting a diagnosis

    ObjectiveThe Montreal Cognitive Assessment (MoCA) Memory Index Score (MIS) is a supplemental assessment of memory composed of word list delayed free-recall followed by step-down category cued- and multiple-choice cued-recall.

  45. The Relationship Between Brainstem Structural Anatomical Parameters And Cognitive Function Impairment Based On The Indonesian Version Of Montreal Cognitive Assessment Score In Clinical Dementia Patients

    ✓ Peer-reviewed alzhub usefulness score 34 out of 100. Eduvest - Journal Of Universal Studies 2025-08-13 Getting a diagnosis

    Dementia is a neurodegenerative disorder characterized by a significant decline in cognitive function.

  46. Clinical parameters predicted the progression to dementia in oldest old patients with mild cognitive impairment (MCI)

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. International Psychogeriatrics 2025-08-12 Mild cognitive impairment

    Fifty-nine patients fulfilled the inclusion criteria.

  47. Utility of combination of Mini-Mental State Examination and Montreal Cognitive Assessment to predict incident Alzheimer's disease dementia in patients at high vascular risks

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of Alzheimer s Disease 2025-08-06 Getting a diagnosis

    BackgroundScreening for cognitive function, using tests such as the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), is the first step in detecting mild cognitive impairment (MCI) and dementia.

  48. Midlife cognitive testing in Africa: validity of the Harmonised Cognitive Assessment Protocol in the Kenya Life Panel Survey

    ✓ Peer-reviewed alzhub usefulness score 58 out of 100. BMJ Open 2025-08-01 Getting a diagnosis

    Fit of the models to the data was adequate for general cognitive performance (root mean squared error of approximation (RMSEA)=0.03; comparative fit index (CFI)=0.94; standardised root mean residual (SRMR)=0.05), language (RMSEA=0.02; CFI=0.95; SRMR=0.05) and good for memory (RMSEA=0.05; CFI=0.99; SRMR=0.02) and executive functioning (RMSEA=0.03; CFI=0.98; SRMR=0.03).

  49. Sex‐specific association of depressive symptom trajectories with cognitive decline and clinical progression in mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer s & Dementia 2025-08-01 Mild cognitive impairment

    In men, increasing depressive symptoms were associated with significantly steeper rates of cognitive decline, as measured by global cognitive and functional outcomes, and with an increased risk of dementia compared to consistently low depressive symptoms.

  50. Machine Learning–Based Cognitive Assessment With The Autonomous Cognitive Examination: Randomized Controlled Trial

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of Medical Internet Research 2025-07-30 Getting a diagnosis

    The ACoE's overall cognitive assessments were significantly reliable (ICC [intraclass correlation coefficient]=0.89; P<.001).

From across this tag

8 of the 846 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 8. The same 8 appear here every time.

All topic tags with their study counts